Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Finance
Novozymes CEO to step down amid earnings warning
by Melody M. Bomgardner
October 18, 2019
| A version of this story appeared in
Volume 97, Issue 41
Novozymes CEO Peder Holk Nielsen will step down as CEO in early 2020, once a successor is in place. Novozymes says it will implement changes to deliver higher revenue growth, including choosing a leader from outside the company. The Danish enzyme firm has struggled in recent years to achieve growth promises and had to warn investors of earnings shortfalls in October, June, and April. In the most recent warning, Novozymes blames falling or weak demand from US ethanol producers, global agriculture, and starch processors.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X